| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3192712 | Annals of Allergy, Asthma & Immunology | 2009 | 7 Pages |
Abstract
There are no significant differences between formulations for any inflammatory outcome. CBIS has a shorter nebulization time and is given at a quarter of the nominal dose of Pulmicort.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Peter A. MBChB, Daniel MBChB, Arun MBBS, Ahmet MD, Brian J. MD,